In chronic myeloid leukemia (CML), inhibition of autophagy by silencing ATG7 or ATG4B curbs the expansion of CML CD34+ stem/progenitor cells (277, 278). Here, ATG4B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.